Prediction of bronchopulmonary dysplasia

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 6, 2011, Pages

  May, Caroline ^a   Patel, Sabina ^a   Kennedy, Caroline ^a   Pollina, Elena ^b   Rafferty, Gerrard F ^a   Peacock, Janet L ^c   Greenough, Anne ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE;

AREA UNDER THE CURVE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; GESTATIONAL AGE; HUMAN; INFANT; INFLAMMATION; LUNG COMPLIANCE; LUNG DYSPLASIA; LUNG FUNCTION; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYSTEM; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; BIRTH WEIGHT; BREATH TESTS; BRONCHOPULMONARY DYSPLASIA; CARBON MONOXIDE; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG COMPLIANCE; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 80054717961     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2010.189597     Document Type: Article

References (32)

1. Greenough A, Alexander J, Burgess S, et al. High versus restricted use of home oxygen therapy, health care utilisation and the cost of care in chronic lung disease infants. Eur J Pediatr 2004;163:292-6. (Pubitemid 38725532)
2. Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 2001;85:463-8. (Pubitemid 33116475)
3. Koumbourlis AC, Motoyama EK, Mutich RL, et al. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease. Pediatr Pulmonol 1996;21:28-34. (Pubitemid 26104992)
4. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421-31.
5. Williams O, Dimitriou G, Hannam S, et al. Lung function and exhaled nitric oxide levels in infants developing chronic lung disease. Pediatr Pulmonol 2007;42:107-13. (Pubitemid 46214565)
6. May C, Patel S, Peacock J, et al. End-tidal carbon monoxide levels in prematurely born infants developing bronchopulmonary dysplasia. Pediatr Res 2007;61:474-8. (Pubitemid 46569303)
7. Horváth I, MacNee W, Kelly FJ, et al. "Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. Eur Respir J 2001;18:420-30. (Pubitemid 32776420)
8. Lui K, Lloyd J, Ang E, et al. Early changes in respiratory compliance and resistance during the development of bronchopulmonary dysplasia in the era of surfactant therapy. Pediatr Pulmonol 2000;30:282-90.
9. Kavvadia V, Greenough A, Dimitriou G. Early prediction of chronic oxygen dependency by lung function test results. Pediatr Pulmonol 2000;29:19-26. (Pubitemid 30036672)
10. Hey EN. The relation between environmental temperature and oxygen consumption in the new-born baby. J Physiol (Lond) 1969;200:589-603.
11. Thomson A, Silverman M. Single-breath measurement of lung mechanics in very low birth weight infants. Crit Care Med 1985;13:4-8. (Pubitemid 15195809)
12. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9. (Pubitemid 34787629)
13. Fowlie PW, Schmidt B. Diagnostic tests for bacterial infection from birth to 90 days-a systematic review. Arch Dis Child Fetal Neonatal Ed 1998;78:F92-8. (Pubitemid 28201554)
14. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. (Pubitemid 32578778)
15. Hird M, Greenough A, Gamsu H. Gas trapping during high frequency positive pressure ventilation using conventional ventilators. Early Hum Dev 1990;22:51-6. (Pubitemid 20106215)
16. Javier MC, Krauss A, Nesin M. Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs' test-positive term neonates. Pediatrics 2003;112:1333-7. (Pubitemid 37523416)
17. Zegdi R, Perrin D, Burdin M, et al. Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med 2002;28:793-6. (Pubitemid 34639495)
18. Biernacki WA, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide in patients with lower respiratory tract infection. Respir Med 2001;95:1003-5. (Pubitemid 34013551)
19. Graff MA, Novo RP, Diaz M, et al. Compliance measurement in respiratory distress syndrome: the prediction of outcome. Pediatr Pulmonol 1986;2:332-6.
20. Freezer NJ, Sly PD. Predictive value of measurements of respiratory mechanics in preterm infants with HMD. Pediatr Pulmonol 1993;16:116-23.
21. Goldman SL, Gerhardt T, Sonni R, et al. Early prediction of chronic lung disease by pulmonary function testing. J Pediatr 1983;102:613-17. (Pubitemid 13114881)
22. Desai NS, Cunningham MD, Boyer DJ, et al. Predisposing pulmonary dynamics from birth for infants with bronchopulmonary dysplasia. Clin Res 1983;31:908.
23. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693-722. (Pubitemid 32578777)
24. Manczur T, Greenough A, Nicholson GP, et al. Resistance of pediatric and neonatal endotracheal tubes: influence of flow rate, size, and shape. Crit Care Med 2000;28:1595-8. (Pubitemid 30324546)
25. Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-10.
26. Dimitriou G, Greenough A, Sumi K. Performance of a commercially available neonatal respiration monitor. Br J Intensive Care 2001;11:42-6.
27. Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997;99:2992-9. (Pubitemid 27278676)
28. Watterberg KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-15. (Pubitemid 26049651)
29. Van Marter LJ, Dammann O, Allred EN, et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002;140:171-6. (Pubitemid 34183655)
30. Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009;1:CD001146.
31. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001146.
32. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (> 3 weeks) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001145.